Trade $ SingMedical - 5OTsg CFD
Market information is presented
as of 2023-09-21
- Summary
Spread | 0.011 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.021226% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.000692% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | SGD | ||||||||
Margin | 5% | ||||||||
Stock exchange | Singapore | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 0.392 |
Open* | 0.397 |
1-Year Change* | 28.9% |
Day's Range* | 0.392 - 0.397 |
52 wk Range | 0.28-0.40 |
Average Volume (10 days) | 1.36M |
Average Volume (3 months) | 37.61M |
Market Cap | 194.65M |
P/E Ratio | 13.24 |
Shares Outstanding | 486.38M |
Revenue | 105.26M |
EPS | 0.03 |
Dividend (Yield %) | 1.625 |
Beta | 0.97 |
Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 19, 2022 | 0.392 | -0.005 | -1.26% | 0.397 | 0.397 | 0.392 |
Dec 16, 2022 | 0.392 | -0.005 | -1.26% | 0.397 | 0.397 | 0.392 |
Dec 15, 2022 | 0.392 | -0.005 | -1.26% | 0.397 | 0.397 | 0.392 |
Dec 14, 2022 | 0.392 | 0.000 | 0.00% | 0.392 | 0.392 | 0.392 |
Dec 9, 2022 | 0.392 | 0.000 | 0.00% | 0.392 | 0.392 | 0.392 |
Dec 8, 2022 | 0.392 | 0.000 | 0.00% | 0.392 | 0.392 | 0.392 |
Dec 6, 2022 | 0.392 | 0.000 | 0.00% | 0.392 | 0.392 | 0.392 |
Dec 2, 2022 | 0.392 | 0.000 | 0.00% | 0.392 | 0.392 | 0.392 |
Dec 1, 2022 | 0.392 | 0.000 | 0.00% | 0.392 | 0.392 | 0.392 |
Nov 29, 2022 | 0.392 | 0.000 | 0.00% | 0.392 | 0.392 | 0.392 |
Nov 28, 2022 | 0.392 | 0.000 | 0.00% | 0.392 | 0.392 | 0.392 |
Nov 25, 2022 | 0.392 | 0.000 | 0.00% | 0.392 | 0.392 | 0.392 |
Nov 22, 2022 | 0.392 | 0.010 | 2.62% | 0.382 | 0.392 | 0.382 |
Nov 21, 2022 | 0.382 | -0.005 | -1.29% | 0.387 | 0.387 | 0.382 |
Nov 18, 2022 | 0.387 | 0.000 | 0.00% | 0.387 | 0.387 | 0.382 |
Nov 17, 2022 | 0.382 | 0.000 | 0.00% | 0.382 | 0.382 | 0.382 |
Nov 16, 2022 | 0.387 | 0.000 | 0.00% | 0.387 | 0.387 | 0.382 |
Nov 15, 2022 | 0.382 | 0.000 | 0.00% | 0.382 | 0.382 | 0.382 |
Nov 11, 2022 | 0.382 | 0.000 | 0.00% | 0.382 | 0.387 | 0.382 |
Nov 10, 2022 | 0.387 | 0.005 | 1.31% | 0.382 | 0.387 | 0.382 |
$ SingMedical Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total revenue | 100.84 | 87.34 | 94.672 | 85.069 | 68.001 |
Revenue | 100.84 | 87.34 | 94.672 | 85.069 | 68.001 |
Cost of Revenue, Total | 56.58 | 49.3 | 51.431 | 47.274 | 39.027 |
Gross Profit | 44.26 | 38.04 | 43.241 | 37.795 | 28.974 |
Total Operating Expense | 83.175 | 76.269 | 77.472 | 69.921 | 57.541 |
Selling/General/Admin. Expenses, Total | 28.229 | 23.97 | 26.128 | 23.087 | 18.8 |
Interest Expense (Income) - Net Operating | -0.03 | -0.075 | -0.1 | -0.071 | -0.059 |
Unusual Expense (Income) | 1.142 | 3.15 | 0.146 | 0.062 | 0.04 |
Other Operating Expenses, Total | -2.746 | -0.076 | -0.133 | -0.431 | -0.267 |
Operating Income | 17.665 | 11.071 | 17.2 | 15.148 | 10.46 |
Interest Income (Expense), Net Non-Operating | 0.405 | -0.529 | -1.016 | -0.786 | -0.977 |
Net Income Before Taxes | 18.07 | 10.528 | 16.069 | 14.104 | 9.483 |
Net Income After Taxes | 15.716 | 9.097 | 13.635 | 12.915 | 8.732 |
Minority Interest | -0.108 | -0.367 | 0.026 | 0.013 | -0.233 |
Net Income Before Extra. Items | 15.608 | 8.73 | 13.661 | 12.928 | 8.499 |
Net Income | 15.608 | 8.73 | 13.661 | 12.928 | 8.499 |
Income Available to Common Excl. Extra. Items | 15.608 | 8.73 | 13.661 | 12.928 | 8.499 |
Income Available to Common Incl. Extra. Items | 15.608 | 8.73 | 13.661 | 12.928 | 8.499 |
Diluted Net Income | 15.608 | 8.73 | 13.661 | 12.928 | 8.499 |
Diluted Weighted Average Shares | 484.059 | 482.844 | 508.501 | 472.419 | 427.795 |
Diluted EPS Excluding Extraordinary Items | 0.03224 | 0.01808 | 0.02687 | 0.02737 | 0.01987 |
Diluted Normalized EPS | 0.0343 | 0.02372 | 0.02704 | 0.02716 | 0.01937 |
Other, Net | 0 | -0.014 | -0.115 | -0.258 | |
Dividends per Share - Common Stock Primary Issue | 0.0065 | 0.004 | 0.004 |
Dec 2021 | Jun 2021 | Dec 2020 | Jun 2020 | Dec 2019 | |
---|---|---|---|---|---|
Total revenue | 51.158 | 49.682 | 48.395 | 38.945 | 25.856 |
Revenue | 51.158 | 49.682 | 48.395 | 38.945 | 25.856 |
Cost of Revenue, Total | 29.175 | 27.405 | 26.268 | 23.032 | 14.366 |
Gross Profit | 21.983 | 22.277 | 22.127 | 15.913 | 11.49 |
Total Operating Expense | 42.5 | 40.675 | 42.275 | 33.994 | 21.667 |
Selling/General/Admin. Expenses, Total | 14.894 | 13.335 | 12.868 | 11.102 | 7.263 |
Interest Expense (Income) - Net Operating | -0.011 | -0.019 | -0.015 | -0.06 | -0.034 |
Unusual Expense (Income) | 0.011 | -0.011 | 0.167 | 0.146 | |
Other Operating Expenses, Total | -1.569 | -0.035 | 2.987 | -0.08 | -0.074 |
Operating Income | 8.658 | 9.007 | 6.12 | 4.951 | 4.189 |
Interest Income (Expense), Net Non-Operating | 0.468 | -0.063 | 0.313 | -0.856 | 0.084 |
Net Income Before Taxes | 9.126 | 8.944 | 6.433 | 4.095 | 4.273 |
Net Income After Taxes | 7.989 | 7.727 | 5.614 | 3.483 | 3.61 |
Minority Interest | 0.429 | -0.537 | -0.338 | -0.029 | 0.073 |
Net Income Before Extra. Items | 8.418 | 7.19 | 5.276 | 3.454 | 3.683 |
Net Income | 8.418 | 7.19 | 5.276 | 3.454 | 3.683 |
Income Available to Common Excl. Extra. Items | 8.418 | 7.19 | 5.276 | 3.454 | 3.683 |
Income Available to Common Incl. Extra. Items | 8.418 | 7.19 | 5.276 | 3.454 | 3.683 |
Diluted Net Income | 8.418 | 7.19 | 5.276 | 3.454 | 3.683 |
Diluted Weighted Average Shares | 485.474 | 482.644 | 482.947 | 482.741 | 506.48 |
Diluted EPS Excluding Extraordinary Items | 0.01734 | 0.0149 | 0.01092 | 0.00715 | 0.00727 |
Dividends per Share - Common Stock Primary Issue | 0.0065 | 0 | 0.004 | 0 | 0.004 |
Diluted Normalized EPS | 0.01733 | 0.01487 | 0.01122 | 0.00713 | 0.00747 |
Other, Net | 0 | 0 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Current Assets | 35.968 | 34.911 | 37.386 | 30.549 | 30.86 |
Cash and Short Term Investments | 26.618 | 25.623 | 27.316 | 20.012 | 21.326 |
Cash | 26.618 | 25.623 | 27.316 | 20.012 | 21.326 |
Total Receivables, Net | 6.494 | 6.757 | 7.288 | 7.068 | 6.871 |
Accounts Receivable - Trade, Net | 5.968 | 5.268 | 5.631 | 6.031 | 4.749 |
Total Inventory | 1.961 | 1.828 | 1.8 | 1.694 | 1.521 |
Prepaid Expenses | 0.895 | 0.703 | 0.982 | 1.775 | 1.142 |
Total Assets | 201.837 | 190.538 | 197.618 | 181.844 | 167.631 |
Property/Plant/Equipment, Total - Net | 19.639 | 16.657 | 20.749 | 13.652 | 13.506 |
Intangibles, Net | 0.563 | 0.811 | 0.82 | 0.442 | 0 |
Long Term Investments | 19.786 | 11.5 | 8.902 | 7.356 | 1.532 |
Note Receivable - Long Term | 1.639 | 2.828 | 2.906 | 2.9 | 1.495 |
Other Long Term Assets, Total | 0.829 | 0.73 | 0.754 | 0.844 | 1.039 |
Total Current Liabilities | 26.471 | 29.368 | 40.67 | 37.804 | 33.518 |
Accounts Payable | 2.075 | 1.886 | 2.12 | 1.648 | 1.912 |
Notes Payable/Short Term Debt | 0 | 0 | 9.201 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 6.298 | 10.441 | 11.589 | 6.219 | 3.21 |
Other Current Liabilities, Total | 8.692 | 8.325 | 17.76 | 29.937 | 28.396 |
Total Liabilities | 33.888 | 36.454 | 51.667 | 51.066 | 59.348 |
Total Long Term Debt | 7.888 | 6.992 | 11.092 | 11.704 | 8.272 |
Long Term Debt | 2.188 | 3.649 | 5.295 | 9.98 | 7.375 |
Capital Lease Obligations | 5.7 | 3.343 | 5.797 | 1.724 | 0.897 |
Deferred Income Tax | 0.532 | 0.259 | 0.228 | 0.17 | 0.103 |
Minority Interest | -1.411 | -0.573 | -0.702 | -0.45 | 0.05 |
Other Liabilities, Total | 0.408 | 0.408 | 0.379 | 1.838 | 17.405 |
Total Equity | 167.949 | 154.084 | 145.951 | 130.778 | 108.283 |
Common Stock | 121.028 | 119.838 | 119.789 | 118.918 | 108.738 |
Retained Earnings (Accumulated Deficit) | 47.594 | 33.243 | 26.246 | 12.502 | -0.343 |
Other Equity, Total | -0.623 | -0.261 | -0.042 | -0.642 | -0.112 |
Total Liabilities & Shareholders’ Equity | 201.837 | 190.538 | 197.618 | 181.844 | 167.631 |
Total Common Shares Outstanding | 486.382 | 482.61 | 482.882 | 459.415 | 459.416 |
Property/Plant/Equipment, Total - Gross | 35.243 | 31.973 | 35.222 | 27.802 | 23.967 |
Accumulated Depreciation, Total | -15.604 | -15.316 | -14.473 | -14.15 | -10.461 |
Goodwill, Net | 123.413 | 123.101 | 126.101 | 126.101 | 119.199 |
Treasury Stock - Common | -0.05 | -0.089 | -0.042 | ||
Accrued Expenses | 9.406 | 8.716 | |||
Unrealized Gain (Loss) | 0 | 1.353 |
Dec 2021 | Jun 2021 | Dec 2020 | Jun 2020 | Dec 2019 | |
---|---|---|---|---|---|
Total Current Assets | 35.968 | 34.149 | 34.911 | 29.304 | 37.386 |
Cash and Short Term Investments | 26.618 | 24.665 | 25.623 | 20.254 | 27.316 |
Cash | 26.618 | 24.665 | 25.623 | 20.254 | 27.316 |
Total Receivables, Net | 6.494 | 6.421 | 6.757 | 5.904 | 7.288 |
Accounts Receivable - Trade, Net | 5.968 | 5.537 | 5.268 | 4.218 | 5.631 |
Total Inventory | 1.961 | 1.864 | 1.828 | 2.09 | 1.8 |
Prepaid Expenses | 0.895 | 1.199 | 0.703 | 1.056 | 0.982 |
Total Assets | 201.837 | 188.331 | 190.538 | 192.079 | 197.618 |
Property/Plant/Equipment, Total - Net | 19.639 | 15.669 | 16.657 | 23.118 | 20.749 |
Intangibles, Net | 123.976 | 123.917 | 123.912 | 126.828 | 126.921 |
Long Term Investments | 19.786 | 11.026 | 11.5 | 9.416 | 8.902 |
Note Receivable - Long Term | 1.639 | 2.843 | 2.828 | 2.643 | 2.906 |
Other Long Term Assets, Total | 0.829 | 0.727 | 0.73 | 0.77 | 0.754 |
Total Current Liabilities | 26.471 | 24.42 | 29.368 | 33.046 | 40.67 |
Accounts Payable | 2.075 | 1.981 | 1.886 | 2.436 | 2.12 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 9.201 |
Current Port. of LT Debt/Capital Leases | 6.298 | 7.653 | 10.441 | 10.54 | 11.589 |
Other Current Liabilities, Total | 18.098 | 14.786 | 17.041 | 20.07 | 17.76 |
Total Liabilities | 33.888 | 29.617 | 36.454 | 45.009 | 51.667 |
Total Long Term Debt | 7.888 | 4.572 | 6.992 | 11.962 | 11.092 |
Long Term Debt | 2.188 | 2.599 | 3.649 | 2.789 | 5.295 |
Capital Lease Obligations | 5.7 | 1.973 | 3.343 | 9.173 | 5.797 |
Deferred Income Tax | 0.532 | 0.366 | 0.259 | 0.295 | 0.228 |
Minority Interest | -1.411 | -0.149 | -0.573 | -0.673 | -0.702 |
Other Liabilities, Total | 0.408 | 0.408 | 0.408 | 0.379 | 0.379 |
Total Equity | 167.949 | 158.714 | 154.084 | 147.07 | 145.951 |
Common Stock | 121.028 | 119.888 | 119.838 | 119.836 | 119.789 |
Retained Earnings (Accumulated Deficit) | 47.594 | 38.497 | 33.243 | 27.842 | 26.246 |
Treasury Stock - Common | -0.05 | -0.05 | -0.089 | -0.089 | -0.042 |
Other Equity, Total | -0.623 | -0.39 | -0.261 | -0.519 | -0.042 |
Total Liabilities & Shareholders’ Equity | 201.837 | 188.331 | 190.538 | 192.079 | 197.618 |
Total Common Shares Outstanding | 486.382 | 482.789 | 482.61 | 482.611 | 482.882 |
Unrealized Gain (Loss) | 0 | 0.769 | 1.353 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net income/Starting Line | 18.07 | 10.528 | 16.069 | 14.104 | 9.483 |
Cash From Operating Activities | 24.467 | 20.907 | 26.109 | 17.44 | 12.788 |
Cash From Operating Activities | 8.915 | 8.959 | 8.933 | 3.882 | 2.646 |
Non-Cash Items | -1.794 | 2.444 | 1.527 | 1.174 | 1.008 |
Cash Interest Paid | 0.488 | 1.199 | 1.003 | 0.76 | 0.471 |
Changes in Working Capital | -1.177 | -1.389 | -0.665 | -1.8 | -0.349 |
Cash From Investing Activities | -9.688 | -3.365 | -18.745 | -28.682 | -22.223 |
Capital Expenditures | -4.229 | -1.572 | -2.143 | -3.42 | -5.014 |
Other Investing Cash Flow Items, Total | -5.459 | -1.793 | -16.602 | -25.262 | -17.209 |
Cash From Financing Activities | -13.784 | -19.235 | -0.06 | 9.953 | 22.937 |
Financing Cash Flow Items | -1.063 | -0.3 | -0.38 | -0.537 | -0.627 |
Issuance (Retirement) of Stock, Net | 0.553 | -0.084 | 0.676 | 7.088 | 15.933 |
Issuance (Retirement) of Debt, Net | -11.344 | -16.921 | -0.356 | 3.402 | 7.631 |
Net Change in Cash | 0.995 | -1.693 | 7.304 | -1.289 | 13.502 |
Amortization | 0.453 | 0.365 | 0.245 | 0.08 | 0 |
Cash Taxes Paid | 2.018 | 1.418 | 1.888 | 0.924 | 0.091 |
Total Cash Dividends Paid | -1.93 | -1.93 |
Dec 2021 | Jun 2021 | Dec 2020 | Jun 2020 | Dec 2019 | |
---|---|---|---|---|---|
Net income/Starting Line | 18.07 | 8.944 | 10.528 | 4.095 | 16.069 |
Cash From Operating Activities | 24.467 | 9.8 | 20.907 | 9.794 | 26.109 |
Cash From Operating Activities | 8.915 | 4.385 | 8.959 | 4.513 | 8.933 |
Amortization | 0.453 | 0.187 | 0.365 | 0.168 | 0.245 |
Non-Cash Items | -1.794 | 0.166 | 2.444 | 1.126 | 1.527 |
Cash Taxes Paid | 2.018 | 1.671 | 1.418 | 0.057 | 1.888 |
Cash Interest Paid | 0.488 | 0.278 | 1.199 | 0.806 | 1.003 |
Changes in Working Capital | -1.177 | -3.882 | -1.389 | -0.108 | -0.665 |
Cash From Investing Activities | -9.688 | -3.194 | -3.365 | -0.928 | -18.745 |
Capital Expenditures | -4.229 | -3.212 | -1.572 | -0.525 | -2.143 |
Other Investing Cash Flow Items, Total | -5.459 | 0.018 | -1.793 | -0.403 | -16.602 |
Cash From Financing Activities | -13.784 | -7.564 | -19.235 | -15.928 | -0.06 |
Financing Cash Flow Items | -1.063 | -0.16 | -0.3 | -0.38 | |
Issuance (Retirement) of Stock, Net | 0.553 | 0 | -0.084 | -0.084 | 0.676 |
Issuance (Retirement) of Debt, Net | -11.344 | -5.474 | -16.921 | -15.844 | -0.356 |
Net Change in Cash | 0.995 | -0.958 | -1.693 | -7.062 | 7.304 |
Total Cash Dividends Paid | -1.93 | -1.93 | -1.93 |
SingMedical Company profile
About Singapore Medical Group Ltd
Singapore Medical Group Limited is a Singapore-based company that is engaged in the operation of medical clinics, provision of general medical services and investment holdings. The Company operates through three segments. The Health Business segment consists of obstetrical and gynecological services; oncology services including the prevention, diagnosis and treatment of cancer, cancer screening and cancer genetic and risk assessment; pediatrics services; general medicine and health screening services; cardiology services, and endocrinology services. The Diagnostic & Aesthetics Business segment consists of radiology and diagnostic imaging services; refractive surgery services; dental services including general dental services, prosthodontics, orthodontics, implant dentistry, oral surgery and gum treatment, and aesthetics medicine services. Its Others segment consists of group-level corporate services as well as business consultancy functions and telemedicine services.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Singapore Medical Group Ltd revenues increased 15% to SP$100.8M. Net income increased 79% to SP$15.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Interest Expense decrease of 74% to SP$159K (expense), Share of results of joint ventures and a increase of 98% to SP$898K (income).
Equity composition
01/2014, Rights Issue, 1 new shares for every 2 shares held @ 0.105 SGD (Factor: 1.058824).12/2014, Rights Issue, 1 new share for every 10 shares held @ SGD 0.153 Factor(1.0)
Industry: | Healthcare Facilities & Services (NEC) |
1004 Toa Payoh North
Floor 06 Unit 03 07
318995
SG
News

EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023
Cable coils near lows ahead of Fed and BoE rate decisions
It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.
14:16, 19 September 2023
FTSE 100 Technical Outlook - 18 September 2023
In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.
06:55, 19 September 2023
Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally
The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.
13:46, 15 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com